Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Innovation Pharmaceuticals IPIX
Posted On: 02/20/2016 9:16:02 AM
Post# of 72446
Posted By: takingabath
Re: Drano #18817
Drano we will have 6 trials this year(min.) and not long running "hope it doesn't hurt anyone" Phase1 trials either.
We are talking 5 Phase2 and 1 Phase3(min).

Kevetrin Ovarian Phase 2 Orphan Designation
Kevetrin Pancreatic Phase 2 Orphan Designation
Brilacidin OM Phase 2 Fast Track

Brilacidin Absssi Phase 3 QIDP
Brilacidin Ulcerative Proctitis(should make Scotty and his partner happy) Phase2

Prurisol Phase2 505 Designation

5 of these trials are getting boosts from the FDA to speed things up and 3 are currently running. Think that is a coincidence? Leo knows what he is doing.
He could have chosen Kevetrin for Lung cancer but wouldn't have gotten Orphan and the trial would take much longer.

If Prurisol works in Phase2 then Phase3 will go like a bat out of hell because 505 designation allows for a much smaller patient enrollment.

I dare ANYONE to find a better or equal to pipeline anywhere!!!!
So what if Prurisol fails.......But what if it works
The only people selling anyway will be noretreat and his band of assholes.
It won't matter by then anyway.....

Don't be surprised if we see these 3 words this year for Kevetrin...
"BREAKTHROUGH THERAPY DESIGNATION"













(5)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site